Could the UAE’s approval of the Wegovy (semaglutide) weight-loss pill change how obesity and related health conditions are treated?

The Emirates Drug Establishment has approved the once-daily oral treatment for adults with obesity or overweight linked to weight-related medical conditions, making the UAE only the second country in the world to authorise it. Clinical studies indicate that, alongside diet and exercise, the medication can support long-term weight loss and may reduce the risk of serious cardiovascular events such as heart attacks, strokes, and cardiovascular-related deaths in high-risk patients. What do you think — could innovative treatments like this improve public health outcomes, or should lifestyle changes remain the primary focus in tackling obesity?

Add your Comment:

+